Explore the evolving landscape of transcatheter treatment for aortic regurgitation in this informative session. Understand the anatomical and clinical criteria essential for selecting candidates for transcatheter therapy, review the latest device options supported by real-world and investigational data, and learn to navigate procedural challenges with advanced...

Enhance your diagnostic accuracy in aortic stenosis through this targeted session. Learn to differentiate among various types of aortic stenosis, avoid common echocardiographic diagnostic errors, and master transesophageal echocardiography (TEE) measurement techniques to effectively guide transcatheter aortic valve implantation (TAVI), especially in emergency settings.

Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21